Dave Shove

BMO Capital Markets analysts Dave Shove and Jennifer Lynch reiterated their Market Perform rating for shares of Centene Corp (NYSE: CNC) with a price target of $21. Centene Corp recently announced the purchase of Carolina Crescent Health Plan, which prompted the BMO Capital Markets analysts to...